实用医学杂志 ›› 2022, Vol. 38 ›› Issue (6): 773-778.doi: 10.3969/j.issn.1006⁃5725.2022.06.024

• 调查研究 • 上一篇    下一篇

广东省脐带血造血干细胞库应用数据分析

  

  1. 1 广东省脐带血造血干细胞库(广州 510663);2 广州市天河诺亚生物工程有限公司(广州 510663); 3 广东省妇幼保健院(广州 523146);4 华南理工大学附属第六医院佛山市南海区人民医院血液肿瘤科 (广东佛山 528200)
  • 出版日期:2022-03-25 发布日期:2022-03-25
  • 通讯作者: 张复华 E⁃mail:417281439@qq.com
  • 基金资助:
    广州市科技计划项目(编号:201807010004)

An analysis on the application data from Institution of Guangdong Cord Blood Bank

SHI Congying*, ZHOU Haiyang,WEI Wei,HUANG Wanjun,WANG Qi,ZHANG Fuhua.   

  1. Institution of Guangdong Cord Blood Bank,Guangzhou 510663,China;*Guangzhou Municipality TianheNuoya Bio⁃engineering Co.,Ltd,Guangzhou 510663,China

  • Online:2022-03-25 Published:2022-03-25
  • Contact: ZHANG Fuhua E⁃mail:417281439@qq.com

摘要:

目的 利用广东省脐带血造血干细胞库的临床应用数据,总结脐血在广东省内临床应用现 况及其影响因素和治疗效果。方法 对广东脐血库 2007-2020 2 132 份临床应用脐血的应用疾病类型、 脐血相关质量指标、应用后的植入情况、总生存率等数据进行统计分析。结果 广东省脐血库公共库脐 血目前治疗的主要疾病是血液病(87.3%)。脐血治疗的疾病类型与应用地区、性别、单个核细胞数、治疗 类型和 HLA 配型情况差异均有统计学意义(P < 0.01)。疾病类型、治疗类型、植入情况与第二年总生存率 显著相关(P < 0.01)。自体脐血临床应用中,除了血液病以外,应用最多的是神经再生方向;自体脐血治疗的疾病分类与性别、年龄、体重、TNC、冻存血量显著相关(P < 0.01)。结论 目前临床上脐血治疗的疾 病与应用地区、性别等多个因素相关,以血液病治疗为主,并逐渐向神经再生等应用方向延伸,体现出脐 血用于临床治疗的巨大潜力。

关键词:

脐血, 移植, 输注, 干细胞

Abstract:

Objective To summarize the latest clinical application characteristics,influencing factors and therapeutic effects of umbilical cord blood(UCB)in Guangdong province,by using the clinical application data from Institution of Guangdong Cord Blood Bank. Methods The clinical application data on 2 132 cord blood samples from Institution of Guangdong Cord Blood Bank from 2007 to 2020 were statistically analyzed,including the types of diseases treated with umbilical cord blood,indexes of cord blood quality,implantation situation after application,and overall survival rate. Results The main disorders treated with UCB from the public banks in Guangdong were blood diseases(87.3%). There were significant differences in disease type,application area sex,mononuclear cell number,treatment type and human leukocyte antigen(HLA)⁃matched condition(P < 0.01). The overall survival rate in the second year was significantly correlated with disease type ,treatment type and implantation status(P < 0.01). In addition to hematologic diseases,autologous UCB was mostly used in nerve regeneration. Classification of the diseases treated with autologous cord blood was significantly correlated with gender,age,body weight,TNC and frozen blood volume(P < 0.01). Conclusions The diseases clinically treated with UCB are related to multiple factors such as application area and gender. UCB is mainly used for blood diseas⁃ es,and gradually extended to apply to the treatment of nerve regeneration,showing great potential of cord blood in clinical treatment.

Key words:

cord blood, transplantation, infusion, stem cells